(Q37636347)

21 August 2017

1 reference

title

Statins and amyotrophic lateral sclerosis--the level of evidence for an association (English)

1 reference

amyotrophic lateral sclerosis

21 August 2017

main subject

0 references

author name string

H Toft Sørensen

series ordinal

1

1 reference

21 August 2017

T L Lash

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Journal of Internal Medicine

21 August 2017

published in

1 reference

21 August 2017

volume

266

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

520-526

1 reference

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Early statin initiation and outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

The safety of statins in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statins and blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Beyond the laboratory: clinical implications for statin pleiotropy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

21 January 2018

Statin induced myopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statin safety: an overview and assessment of the data--2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statin-associated adverse effects beyond muscle and liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Amyotrophic lateral sclerosis in Sweden, 1991-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Dyslipidemia in ALS: good, bad, or unclear?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Are statin medications safe in patients with ALS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

The reporting odds ratio and its advantages over the proportional reporting ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2009.02173.X

10.1111/J.1365-2796.2009.02173.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference